Big Move For Evoke Pharma, Inc.
Wed, Jul 09, 2025 at 07:14 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) soared at $6.99, a gain of 162.8%. On Wed, Jul 09, 2025, EVOK:NASDAQ hit a New 2-Week High of $6.99. The stock appeared on our News Catalysts scanner on Wed, Jul 09, 2025 at 10:42 AM in the 'PATENT' category. From Wed, Jun 25, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Wed, Jul 09, 2025 at $9.88 with a volume of 139M+.
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 250%
- SU Group Holdings Limited (SUGP:NASDAQ), 171.41%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 162.78%
- Calidi Biotherapeutics, Inc. (CLDI:NYSEMKT), 108.96%
- Basel Medical Group Ltd (BMGL:NASDAQ), 98.9%
- Scage Future (SCAG:NASDAQ), 56.67%
- EpicQuest Education Group International Limited (EEIQ:NASDAQ), 49.89%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%
- SeaChange International, Inc. (SEAC:NASDAQ), 48.94%
- SHF Holdings, Inc. (SHFS:NASDAQ), 46.38%